Population Health Sciences

You are here

Publications

Found 68 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is V  [Clear All Filters]
2020
Benda NC, Veinot TC, Sieck CJ, Ancker JS.  2020.  Broadband Internet Access Is a Social Determinant of Health!. Am J Public Health. 110(8):1123-1125.
Dinh CT, Linn KA, Isidro U, Emanuel EJ, Volpp KG, Bond AM, Caldarella K, Troxel AB, Zhu J, Yang L et al..  2020.  Changes in Outpatient Imaging Utilization and Spending Under a New Population-Based Primary Care Payment Model.. J Am Coll Radiol. 17(1 Pt B):101-109.
Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, J Cairncross G, Wick W, Weller M et al..  2020.  CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.. Neuro Oncol.
Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, J Cairncross G, Wick W, Weller M et al..  2020.  CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.. Neuro Oncol.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Molina AM, van der Mijn JC, Christos P, Wright J, Thomas C, Dutcher JP, Nanus DM, Tagawa ST, Gudas LJ.  2020.  NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma.. Invest New Drugs.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Xie Y, Valdimarsdóttir UA, Wang C, Zhong XR, Gou Q, Zheng H, Deng L, He P, Hu K, Fall K et al..  2020.  Public health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China.. Int J Cancer.
Shoag JE, Gaffney C, Pantuck M, Sun T, Gorin M, Schaeffer E, Sedrakyan A, Vickers A, Hu J.  2020.  Risk Factors for Infection after Prostate Biopsy in the United States.. Urology. 138:113-118.
Jain RK, Lee E, Mathai C, Dako F, Gogineni P, Weiner MG, Vokes T.  2020.  Using opportunistic screening with abdominal CT to identify osteoporosis and osteopenia in patients with diabetes.. Osteoporos Int.